Abstract
Chimeric antigen receptor (CAR) T cell therapy mediates unprecedented benefit in certain leukemias and lymphomas, but has yet to achieve similar succe......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
